David Lubner - Jul 6, 2021 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role: Director
Signature: /s/ William L. Demers, by Power of Attorney for David Charles Lubner
Stock symbol: PNT
Transactions as of: Jul 6, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/8/2021, 04:38 PM
Previous filing: May 27, 2021
Next filing: Mar 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PNT	Stock Option (Right to Buy)	Award	$0	+25K		$0.00	25K	Jul 6, 2021	Common Stock	25K	$8.47	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests 25% on July 6, 2022 with the remaining 75% vesting in three equal annual installments thereafter.

Remarks:

Power of Attorney is attached to this Form 4 as Exhibit 24